Suitability Semaglutide: This drug is suitable for individuals with a BMI of 30 or higher or a BMI of 27 or higher with weight-related health conditions such as hypertension, type 2 diabetes, or dyslipidemia
Less commonly recognized but still valid qualifying conditions include prediabetes (elevated fasting glucose or A1C between 5.7-6.4%), polycystic ovary syndrome, non-alcoholic fatty liver disease, osteoarthritis of weight-bearing joints, and chronic kidney disease
Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability
Leigh Purvis, director of health-care costs and access for AARPs Public Policy Institute, believes this is due to intentional misdirection on the part of drugmakers who are eager to divert blame from their own pricing activity
I really appreciated everyone at Synergy they are so kind and professional